Advisory Board and Editors Bioengineering
Ross H Miller
Dr. Miller is an Associate Professor in the Department of Kinesiology at the University of Maryland (College Park, MD, USA). His research focuses on the mechanics and energetics of human locomotion in health and pathology, with an emphasis on causes and prevention of knee osteoarthritis.
Thimios A Mitsiadis
Professor of Oral Biology in the Medical Faculty at the University of Zurich, Switzerland since 2006. Research in the fields of stem cells, genetics, molecular and experimental biology related to orofacial developmental and regeneration processes.
DDS degree from the Dental Faculty of the Kapodistrion University of Athens (Greece), Master degree for Immunology, Genetics and Differentiation, and PhD in Developmental Biology from the University of Lyon (France). Postdoctoral studies at the University of Helsinki (Finland), Karolinksa Nobel Institute (Stockholm, Sweden) and Yale University (USA). Previously Professor at the Mediterranean University (Marseilles, France), Visiting Professor at the Ecole Normale Superieure of Lyon (France), Clinical Senior Lecturer at King's College London (UK), Visiting Professor at the Polytechnic University of Marche (Ancona, Italy), Visiting Professor at the Second University of Napoli (Napoli, Italy). Chief-Editor of the “Frontiers of Craniofacial Biology and Dental Research”, Associate Editor of “Stem Cell Research”, Scientific Editor of “European Cells & Materials”, and part of the editorial board in additional 8 scientific journals. More than 110 original articles in journals such as “Journal of Cell Biology”, “Development”, “Developmental Biology”, “Nature Genetics”, “Science Signaling”, “Scientific Reports”, “Frontiers in Physiology” and more than 200 keynote and invited lectures.
Carlos Fernando Mourão
Dr. Mourao, a distinguished Brazilian dental surgeon, obtained his Doctor of Dental Surgery (DDS) degree from Universidade Estacio de Sa in 2005. He has over 15 years of private practice experience and has developed expertise in Oral and Maxillofacial Surgery (OMFS) and Implant Dentistry.
Between 2014 and 2019, Dr. Mourao held the rank of Lieutenant (Officer) in the Brazilian Navy. He served as a dentist in the Department of Oral and Maxillofacial Surgery and Implant Dentistry. In addition, he is an Assistant Professor at the Department of Periodontology, Tufts University School of Dental Medicine, in Boston, United States.
Dr. Mourao's academic background encompasses a professorship in the Department of OMFS at Universidade Estacio de Sa from 2007 to 2012. Presently, he teaches in the graduate program in Dentistry at Sao Paulo University (USP) and Biotechnology at Fluminense Federal University (UFF).
He earned a Master's degree in Surgical Sciences (2012) from the School of Medicine at the Federal University of Rio de Janeiro (UFRJ), Brazil, where he acquired extensive experience in animal research with rabbits, rats, and pigs. Furthermore, he obtained a Ph.D. in Dentistry (2017) from UFF, Brazil, conducting clinical trials during his studies.
After his doctoral studies, Dr. Mourao completed two postdoctoral fellowships at UFF in Biotechnology (2017-2021) and Oral and Maxillofacial Surgery (2018-2021). He has also demonstrated a strong aptitude for securing federal and private grants to support research projects.
As a researcher, Dr. Mourao's areas of specialization include blood-derived growth factors, bone regeneration, tissue engineering, bone graft analysis, dental implants, and oral surgery. Additionally, he serves as a reviewer for a wide array of national and international academic journals.
Prof. Hamid Mukhtar
Dr. Hamid Mukhtar is Professor of Biotechnology and former Director at Institute of Industrial Biotechnology, GC University, Lahore. He has been actively contributing in teaching and research since 1996 in different areas of Biotechnology including He obtained his doctoral degree in 2006 from GC University, Lahore and then proceeded for Post-doctoral research from Harvard Medical School, Harvard University, USA in 2010. He did his Ph.D. in the field of Bioprocess Technology and his Post-Doc in the field of Stem Cell Technology and Genetics.
Dr. Mukhtar is one of the active scientists of Pakistan who has published more than 200 research papers in peer reviewed national and international scientific journals. He has authored/co-authored 06 books and 05 book chapters. He has supervised 39 B.Sc., 10 M.Sc., 60 M.Phil. and 5 Ph.D. students. He won Fulbright Scholar Award in 2010 to carry out Post-doctoral research in USA and has been conferred upon with a Best University Teacher Award in 2014 by HEC, Pakistan. He is on the Editorial/Review board of a large number of International & national research journals. He is also fellow of few national & international scientific organizations/societies.
Sarwat Naz
Dr. Naz obtained her PhD degree in 2013 from Indian Institute of Science, India. She then moved to USA to conduct her postdoctoral training. She is currently a Scientist at National Cancer Institute at NIH, USA where she conducts clinical and translational research in the field of cancer. Her primary research focus is identification of means to modify the radiation response of tumors without causing damage to surrounding normal tissues. Her research utilizes testing novel agents that target specific molecular pathways important in radiation responses to probe the radio sensitivity of cells/tissues. In her current role at NCI she manages translational research initiatives involving radiation modification, the influence of tumor microenvironment on cancer immunotherapy, and novel molecular imaging platforms to assess tissue metabolism.
Corey Nislow
Corey Nislow's laboratory develops and uses cutting edge tools to address this central question: how can we understand the biological commonalities in all of the life sciences; from embryonic development, to the spread of infectious diseases to better ways to treat cancer. Each of these disciplines can be explained in the context of competition, interaction and evolution. His lab studies the interface between genes and the environment using parallel genome-wide screens, high throughput cell-based assays and next generation sequencing. Most recently, he and his scientific partner, Dr. Guri Giaever, are exploring how laboratory experiments can co-opt evolutionary processes to understand drug action. He enjoys teaching all aspects of biotechnology, genomics and drug discovery. He got his PhD from the University of Colorado, worked at several Biotechnology companies and was at Stanford and University of Toronto before joining UBC in 2013. He has published 161 papers and run 19 marathons.
David B Norman
Odell Fellow in the Natural Sciences at Christ's College Cambridge, University Reader in the Natural Sciences and Curator of Fossil Vertebrates at the Sedgwick Museum of Earth Sciences. Chairman of the Charles Darwin & Galapagos Islands Trust Fund. Associate Editor (and former Editor) of the Zoological Journal of the Linnean Society of London. Council Member of the Cambridge Philosophical Society.
Olorunseun O Ogunwobi
Dr. Ogunwobi obtained a medical degree from the University of Ibadan, Nigeria, a master's degree in biomedicine from the University of Hull, United Kingdom, a master's degree in clinical and translational science from the University of Florida, Gainesville, and a PhD in molecular biology from the University of East Anglia, Norwich, United Kingdom. He was the Founding Director of the Hunter College Center for Cancer Health Disparities Research. He is now the Barnett Rosenberg Professor of Biochemistry and Molecular Biology and Chairperson in the Department of Biochemistry and Molecular Biology at Michigan State University. In addition, he will serve as Co-Director of the forthcoming Center for Cancer Health Equity Research (CCHER) at Michigan State University. He is a translational cancer biologist whose work focuses on molecular mechanisms of progression of solid organ cancers with racial disparities, and on approaches to leverage non-coding RNA biology for potential clinical applications in cancer. His work has been funded by the National Institutes of Health, New York State, Carnegie Corporation of New York, and the National Science Foundation, among others. Dr. Ogunwobi was a Founding Contact Principal Investigator of the Synergistic Partnership for Enhancing Equity in Cancer Health (SPEECH) funded by U54 grants CA221704 and CA221705 from the National Cancer Institute. An author of 74 peer-reviewed journal articles and 3 book chapters, Dr. Ogunwobi has been issued 5 US patents for biotechnology inventions with potential clinical applications in cancer. He is the recipient of the 2022 Hunter College Presidential Award for Excellence in Scholarship or Creative Activity, and selected as a Jefferson Science Fellow by the National Academies of Sciences, Engineering, and Medicine, and as a Fellow of the Academy of Medicine Specialties of Nigeria. He is Co-Founder of UTR Therapeutics, Inc (winner of the 2023 XSeed Award from Deerfield), and NucleoBio, Inc.
Sean P. Palecek
Professor of Chemical & Biological Engineering at the University of Wisconsin - Madison.
Colin Palmer
An engineer by training with a wide interest in low speed aerodynamics and the fluid dynamics of animal locomotion. PhD topic was the flight of the large pterosaurs. Research Associate at the universities of Bristol and Southampton in the UK.
Santosh Pandey
Dr. Santosh Pandey is an Associate Professor in the Department of Electrical and Computer Engineering at Iowa State University.
His research areas include bioengineering, microelectronics, microfluidics, sensors, machine intelligence, plant pathology, electrophysiology, data analytics, and drug screening.
Mariella Pazzaglia
Dr. Mariella Pazzaglia is a Professor in the Department of Psychology and Director of the Clinical Neuroscience Lab at University of Rome " La Sapienza" and Corpo e Azione Lab at IRCCS S. Lucia Hospital.
Dr. Pazzaglia's research aims to ascertain the anatomical and functional aspects of actions and body representation. She studies the clinical, behavioural, and anatomical measures of patients with brain and spinal cord injury to understand the impact of neurological disorders on neurocognitive network.